Starving cancer into submission. EntreMed, Inc.
Wells
W A
WA
D020533:Angiogenesis Inhibitors; D043168:Angiostatins; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D010958:Plasminogen / Q000627:therapeutic use*; D011506:Proteins / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D010446:Peptide Fragments; D011506:Proteins; D013792:Thalidomide; D043168:Angiostatins; D010958:Plasminogen